Cancer stem cells can play an important role in tumorigenesis and tumor progression. However, it is still difficult to detect and isolate cancer stem cells. An alternative approach is to analyse stem cell-associated gene expression. We investigated the coexpression of three stem cell-associated genes, Hiwi, hTERT and survivin, by quantitative real-time-PCR in 104 primary soft-tissue sarcomas (STS). Multivariate Cox's proportional hazards regression analyses allowed correlating gene expression with overall survival for STS patients. Coexpression of all three stem cell-associated genes resulted in a significantly increased risk of tumor-related death. Importantly, tumors of patients with the poorest prognosis were of all four tumor stages, suggesting that their risk is based upon coexpression of stem cell-associated genes rather than on tumor stage.
During the past 6 years, cells with stem cell-like features so-called cancer stem cells have been identified in acute myeloic leukemia, breast cancers, melanoma and tumors of central nervous system (reviewed in Soltysova et al., 2005; Polyak and Hahn, 2006) . Cancer stem cells have the ability of self-renewal and proliferation, and are resistant to drugs, and express typical markers of other stem cells (Soltysova et al., 2005) . However, detection and isolation of cancer stem cells in solid tumors is difficult and their presence is even controversial as discussed by Hill (2006) . An approach for stem cell identification could be expression analysis of stem cellassociated genes. Therefore, in this study, we evaluated the expression of three genes; Hiwi, human telomerase reverse transcriptase (hTERT) and survivin, which had previously been shown to be overexpressed in both stem cells and cancer cells (Altieri, 2003; Ju and Rudolph, 2006; Liu et al., 2006; Taubert et al., 2007) .
Hiwi belongs to the Piwi-domain proteins, which are components of ribonucleoprotein complexes. Expression of Hiwi has been described in different cancers including seminomas, gastric carcinomas and soft-tissue sarcoma (STS) (Qiao et al., 2002; Liu et al., 2006; Taubert et al., 2007) . In addition, we have recently reported an association between altered expression of Hiwi mRNA and a poor prognosis for STS patients (Taubert et al., 2007) .
hTERT is the catalytic subunit of telomerase, which functions in the synthesis and extension of telomeric DNA. High telomerase activity is observed in more than 85% of human cancer cells, strongly suggesting a key role during tumorigenesis (Pendino et al., 2006) . Furthermore, hTERT expression has been correlated with a poor prognosis in non-small cell lung cancer, Wilm's tumors, B-chronic lymphocytic leukemia and acute myelogenous leukemia (Kirkpatrick and Mokbel, 2001; Zhu et al., 2006) . Previously, we showed that coexpression of survivin and hTERT was an independent negative prognostic factor compared to a low expression of both genes for STS patients (Wu¨rl et al., 2002) .
Survivin is a member of a family of apoptosis inhibitors (Altieri, 2003) . In addition, it is a component of the chromosome passenger protein complex that has been proposed to regulate mitosis (Nguyen and Ravid, 2006) . Therefore, it is considered as an interface molecule between regulation of apoptosis and control of cell proliferation (Altieri, 2003) . Overexpression of survivin has been reported in many tumor tissues including leukemias, lymphomas, STS, colorectal cancers, astrocytic tumors, lung cancer, breast cancer and ovarian tumors (Altieri, 2003; Nguyen and Ravid, 2006) . Overexpression of survivin in malignant tumors has been correlated with a poor prognosis (reviewed in Altieri, 2003) .
In this study, we investigated a cohort of 104 primary STS (originating only from patients before adjuvant therapy and with an average observation time of 51 months) by quantitative real-time PCR for their RNA coexpression of the three stem cell-associated genes Hiwi, hTERT and survivin (Table 1 ). All patients gave written informed consent (Institute of Pathology, University of Halle, Germany and Department of Surgery 1, University of Leipzig, Germany). Measurement of transcript expression levels was performed as described previously (Wu¨rl et al., 2002; Taubert et al., 2007) .
Initially, the impact of expression of a single gene was evaluated. Subsequently, the impact of coexpression of two and then three genes on prognosis of STS patients was determined by multivariate Cox's regression hazard model. Upon analysis of a single gene, increased expression of hTERT (relative risk (RR) ¼ 2.3; P ¼ 0.017) was associated with a worse prognosis of STS patient. However, there was no association between tumors with elevated expression of survivin and prognosis (RR ¼ 1.3; P ¼ 0.37). Both an increased and decreased level of Hiwi mRNA expression significantly correlated with a poor prognosis (RR ¼ 3.1; P ¼ 0.017 and RR ¼ 2.9; P ¼ 0.015, Table 2 ). Only an increased expression of hTERT was associated with a poor outcome, whereas either an elevated or suppressed level of Hiwi expression correlated with a worse prognosis. These data suggest that the maintenance of normal Hiwi expression is critical with respect to tumor therapeutic response and yet Hiwi expression is often deregulated during tumorigenesis. Upon analysis of coexpression of two genes, all possible combinations correlated with a significantly increased risk of tumor-related death. Cooverexpression of survivin and hTERT, of Hiwi and survivin or of Hiwi and hTERT correlated with a 3.6-fold Table 1 Histopathological and clinical data (P ¼ 0.016), 5.5-fold (P ¼ 0.008) or a 6.9-fold (P ¼ 0.004) increased risk of tumor-related death, respectively. Increased expression of either survivin or hTERT when combined with a low expression of Hiwi also correlated with a 3.5-fold (P ¼ 0.03) and a 5.0-fold (P ¼ 0.008) elevated risk of tumor-related death, respectively (Table 2) . When coexpression of all three genes was evaluated, those patients whose tumors possessed an increased expression of Hiwi, hTERT and survivin had a 74.6-fold increased risk of tumor-related death (P ¼ 0.0004) compared with patients with an intermediate level of Hiwi, low survivin and low hTERT mRNA expression (Table 2) . Patients whose tumors expressed low Hiwi, high hTERT and high survivin exhibited a lower but still highly significant (20.1-fold) increased risk of tumor-related death (P ¼ 0.003) compared to the group with an intermediate level of Hiwi expression, low survivin and low hTERT.
To perform additional analyses, the patients were divided into 'risk groups' based upon their expression of Hiwi, survivin and hTERT (for detailed descriptions please refer to figure legend). In a multivariate Cox's regression hazard analysis, an increasing risk of tumorrelated death from group 1 to group 4 was detected. Patients in risk groups 2-4 showed a 5.5-fold (P ¼ 0.06), 7.6-fold (P ¼ 0.025) and a 15.5-fold (P ¼ 0.003), respectively, increased RR of tumor-related death compared with the reference group 1 (Table 2; Figure 1 ). All tumors evaluated were obtained at diagnosis before any therapy. These data suggest that measurement of expression of stem cell-associated genes in primary tumors may allow tumor biological behavior and therapeutic response of STS patients to be predicted. However, before any conclusive statement of this nature can be made, a prospective study will be necessary.
We also evaluated whether the effect of the stem cellassociated gene expression on prognosis was associated with tumor stage. When we considered all risk groups together a significant correlation of stem cell-associated gene expression with the tumor stage was observed (P ¼ 0.0001; Fisher's exact test). However, when the high-risk group 4 was analysed separately all tumor stages were represented approximately equally in this group (stage 1 tumors; 20%, stage 2; 15.9%, stage 3; 19.4% and stage 4; 22.2%). Therefore, patients were classified as high risk based upon tumor expression of stem cell-associated genes and this high-risk status is independent of their tumor stage. In risk group 4, 2/3 stage-1 patients (66%), 2/7 stage-2 patients (28.6%) and all stage-3 and -4 patients have died. In the other three risk groups, only 1/12 stage-1 patients (8%), 13/37 (35%) stage-2 patients, 14/29 (48%) stage-3 patients and all seven stage-4 patients died. This observation suggests that there is a group of patients with a high RR of tumor-related death that appears to be based upon coexpression of stem cell-associated genes rather than on tumor stage. Abbreviations: ag, attogram; RR, relative risk. The cut-off levels for expression of hTERT and survivin were set at the median expression level, whereas the cut-off for Hiwi was based upon box-blot analysis as previously described (Taubert et al., 2007) . Accordingly, the expression levels for survivin were determined as low or high when the relative values were o3.8 or X3.8 zeptomol survivin per attomol housekeeping gene transcript, respectively. For hTERT expression was defined as low or high when the relative values were o0.28 or X0.28 hTERT per housekeeping gene mRNA, respectively. Relative expression levels of Hiwi were defined as high, intermediate, and low when the relative values were: >1.5 ag Hiwi, >0.05 to p1.5 ag Hiwi and p0.05 ag Hiwi/ ag housekeeping gene transcript, respectively, as described previously (Taubert et al., 2007) . 
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The dramatic difference in patient survival when a tumor coexpresses all three genes (Hiwi, hTERT and survivin) demonstrates that each one plays a role in influencing tumor prognosis. These data also suggest that each of the encoded proteins is involved in separate pathways. However, upon searching published literature, an interaction between survivin and hTERT has been described. Survivin can mediate an increase in hTERT expression and activity by enhancing the DNAbinding activities of Sp1 and c-Myc to hTERT core promoter (Endoh et al., 2005) . In this manner, survivin appears to play a role in gene-transcription control by acting as coactivator of hTERT transcription (Endoh et al., 2005) . However, we observed no correlation between hTERT and survivin mRNA expression (P ¼ 0.43, in w 2 -test) demonstrating that these genes are not always coexpressed.
hTERT, the catalytic subunit of telomerase, is responsible for maintaining constant telomere length during chromosome replication resulting in a prolonged cellular life span (Pendino et al., 2006) . Expression of telomerase can have self-renewal potential in hematopoietic cells (Morrison et al., 1996) . In addition, telomerase has been shown to modulate expression of growth-controlling genes and enhance cell proliferation by upregulating growth factors and downregulating apoptosis-inducing genes (Smith et al., 2003) .
Hiwi is a member of the piwi protein family that plays an important role in stem cell self renewal, RNA silencing and translational regulation (Lingel and Sattler, 2005) . Overexpression of Piwi, the Drosophila homologue, causes an increase both in the number of germline stem cells and in the rate of their divisions (Qiao et al., 2002) . Overexpression of Mili, one of three mouse Piwi homologues, inhibits apoptosis and stimulates proliferation (Lee et al., 2006) . Mili and another mouse homologue, Miwi, can form complexes with Piwi-interacting RNAs. These complexes appear to play a regulatory role during mammalian spermatogenesis either through transcriptional and translational repression or by supporting chromosome homology searching and chromosome pairing (Aravin et al., 2006; Girard et al., 2006) .
All three of the proteins evaluated, Hiwi, hTERT and survivin, can act as regulators of transcription, cell division and apoptosis both in normal and cancer stem cells. As regulators of transcription they collectively have the potential to influence the expression of hundreds of other genes. However, further work will be required to understand exactly which growth or apoptotic pathways might be affected by the deregulation of these protein in tumor cells and why overexpression of all these genes has such a major impact on tumor prognosis.
In summary, measurement of expression of three stem cell-associated genes, Hiwi, hTERT and survivin, identifies STS patients with high risk of poor overall survival without direct identification or isolation of cancer stem cells.
Abbreviations ag, attogram; LMS, leiomyosarcoma; MFH, malignant fibrous histiocytoma; NS, neurogenic sarcoma; RMS, rhabdomyosarcoma; RR, relative risk; STS, soft-tissue sarcoma(s).
